Nureca's Q1 Financial Report Shows Decline in Sales and Profit, Receives 'Strong Sell' Rating
Nureca, a microcap company in the medical equipment industry, has reported a negative performance in the quarter ending March 2024, with a decrease in net sales and profit after tax. This has resulted in a 'Strong Sell' rating from MarketsMojo, indicating a decline in the company's overall financial health and a concerning trend for investors.
Nureca, a microcap company in the medical equipment industry, recently announced its financial results for the quarter ending March 2024. The company's stock has been given a 'Strong Sell' rating by MarketsMOJO.
According to the financial report, Nureca has seen a negative performance in the quarter, with a score of -11 compared to -6 in the previous quarter. This indicates a decline in the company's overall financial health.
One of the major factors contributing to this decline is the decrease in net sales, which fell by 29.4% to Rs 16.97 crore compared to the average net sales of the previous four quarters. This trend is expected to continue in the near term.
The company's profit after tax (PAT) also saw a significant decrease of 2124.4% to Rs -4.15 crore, compared to the average PAT of Rs 0.21 crore in the previous four quarters. This is a concerning trend for investors.
Nureca's operating profit (PBDIT) and operating profit margin also hit a low in the last five quarters, with a negative trend expected to continue. The company's efficiency has also deteriorated, as seen in the declining operating profit margin.
Furthermore, the profit before tax (PBT) and earnings per share (EPS) have also hit a low in the last five quarters, indicating a decline in profitability and lower earnings for shareholders.
Overall, Nureca's financial performance for the quarter ending March 2024 has been negative, with a 'Strong Sell' rating from MarketsMOJO. Investors should carefully consider these factors before making any investment decisions.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
